On Invalid Date, Guardant Health (NASDAQ: GH) reported Q2 2023 earnings per share (EPS) of -$0.67, up 70.22% year over year. Total Guardant Health earnings for the quarter were -$72.77 million. In the same quarter last year, Guardant Health's earnings per share (EPS) was -$2.25.
As of Q3 2023, Guardant Health's earnings has grown year over year. Guardant Health's earnings in the past year totalled -$508.23 million.
What is GH's earnings date?
Guardant Health's earnings date is Invalid Date. Add GH to your watchlist to be reminded of GH's next earnings announcement.
What was GH's revenue last quarter?
On Invalid Date, Guardant Health (NASDAQ: GH) reported Q2 2023 revenue of $137.15 million up 25.66% year over year. In the same quarter last year, Guardant Health's revenue was $109.14 million.
What was GH's revenue growth in the past year?
As of Q3 2023, Guardant Health's revenue has grown 25% year over year. This is 23.09 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 1.91%. Guardant Health's revenue in the past year totalled $510.16 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.